Commitments by federal administrations
Commitments of the FAMHP
Through our website,social media and digital applications we ensure transparency of:
Give your opinion on a genetically modified vaccine for the prevention of rabies
PRAC December 2023: recommendation of measures to minimise the risk of serious side effects with medicines containing pseudoephedrine
Annual report on the donation of human body material: increase in the declarations of explicit content and reduction in opposition
Conditions for reuse (Creative Commons-0 licence)
Unless stated otherwise, the information on this website is free of rights and may be used for private, association, scientific and commercial purposes. The FAMHP does, however, recommend stating the source and date of the information that is reused.
Where prior authorisation is required, or where specific conditions are necessary, reuse restrictions are explicitly mentioned. The reuse of multimedia content (photographs, images, sound, videos, etc.), including the content contained in downloadable documents (brochures, etc.), is always subject to prior approval.
Social media
The Federal Agency for Medicines and Health Products uses the following official social media channels: